Richmond Pharmacology is pleased to join Swiss Biotech Day 2026 in Basel, Switzerland, on 4-5 May 2026.

Recognised as one of Europe’s leading biotechnology events, Swiss Biotech Day brings together industry pioneers, investors, research institutions, and global life science innovators to explore new partnerships, cutting‑edge technologies, and the future of biotech‑driven healthcare.

‍

Representing Richmond Pharmacology:

  • Dr Jörg Taubel, Chief Executive Officer
  • ‍Stephen Wilkinson, Business Development Manager

Our Focus at the Conference

  • Emerging biotechnology platforms and novel therapeutic innovations
  • Early‑phase clinical development strategies
  • Regulatory, scientific, and partnering insights for global drug development
  • Collaboration opportunities across Europe’s expanding biotech landscape
  • Strengthening scientific, commercial, and translational partnerships

Connect With Us

If you are attending Swiss Biotech Day 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

‍

Find out more here: Home - Swiss Biotech Day

‍

Latest news

The Future of Cardiometabolic Research: Five Questions Shaping the Next Decade

October 22, 2026
Cardiometabolic research is continually evolving beyond explanations centred on single causes of disease.
Read more

Upcoming Event

AHA Scientific Sessions 2026

14 - 16 November 2026
Richmond Pharmacology is excited to join the AHA Scientific Sessions 2026 in 14–16 November 2026, on 14–16 November 2026, hosted by the American Heart Association.
View event